GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Cencora Inc (MEX:COR) » Definitions » Net Current Asset Value

Cencora (MEX:COR) Net Current Asset Value : MXN-1,892.62 (As of Sep. 2024)


View and export this data going back to 1995. Start your Free Trial

What is Cencora Net Current Asset Value?

In calculating the Net Current Asset Value (NCAV), Benjamin Graham means a company's current assets (such as cash, marketable securities, and inventories) minus its total liabilities (including preferred stock, minority interest, and long-term debt).

Cencora's net current asset value per share for the quarter that ended in Sep. 2024 was MXN-1,892.62.

The historical rank and industry rank for Cencora's Net Current Asset Value or its related term are showing as below:

MEX:COR's Price-to-Net-Current-Asset-Value is not ranked *
in the Medical Distribution industry.
Industry Median: 3.28
* Ranked among companies with meaningful Price-to-Net-Current-Asset-Value only.

Cencora Net Current Asset Value Historical Data

The historical data trend for Cencora's Net Current Asset Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cencora Net Current Asset Value Chart

Cencora Annual Data
Trend Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23 Sep24
Net Current Asset Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only -1,323.78 -1,809.46 -1,676.13 -1,668.72 -1,892.62

Cencora Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Net Current Asset Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1,668.72 -1,610.08 -1,550.17 -1,724.05 -1,892.62

Competitive Comparison of Cencora's Net Current Asset Value

For the Medical Distribution subindustry, Cencora's Price-to-Net-Current-Asset-Value, along with its competitors' market caps and Price-to-Net-Current-Asset-Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cencora's Price-to-Net-Current-Asset-Value Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Cencora's Price-to-Net-Current-Asset-Value distribution charts can be found below:

* The bar in red indicates where Cencora's Price-to-Net-Current-Asset-Value falls into.



Cencora Net Current Asset Value Calculation

Cencora's Net Current Asset Value (NCAV) per share for the fiscal year that ended in Sep. 2024 is calculated as

Net Current Asset Value Per Share(A: Sep. 2024 )
=(Total Current Assets-Total Liabilities-Minority Interest-Preferred Stock)/Shares Outstanding (EOP)
=(939578.054-1305760.769-2772.473-0)/194.944
=-1,892.62

Cencora's Net Current Asset Value (NCAV) per share for the quarter that ended in Sep. 2024 is calculated as

Net Current Asset Value Per Share(Q: Sep. 2024 )
=(Total Current Assets-Total Liabilities-Minority Interest-Preferred Stock)/Shares Outstanding (EOP)
=(939578.054-1305760.769-2772.473-0)/194.944
=-1,892.62

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Cencora  (MEX:COR) Net Current Asset Value Explanation

Benjamin Graham first discussed net current asset value (NCAV) in the 1934 edition of "Security Analysis", which he coauthored with David Dodd. In the book, (net) current asset value is defined as:" current assets alone, minus all liabilities and claims ahead of the issue."

The common definition of NCAV is: NCAV = current assets – [total liabilities + minority interest + preferred stock]

Net current assets exclude not only the intangible assets but also the fixed and miscellaneous assets. In addition, Graham believed that preferred stock belongs on the liability side of the balance sheet, not as part of capital and surplus. In "Security Analysis", preferred stock is dubbed "an imperfect creditorship position" that is best placed on the balance sheet alongside funded debt.

One research study, covering the years 1970 through 1983 showed that portfolios picked at the beginning of each year, and held for one year, returned 29.4 percent, on average, over the 13-year period, compared to 11.5 percent for the S&P 500 Index. Other studies of Graham’s strategy produced similar results.

Benjamin Graham looked for companies whose market values were less than two-thirds of their Net-Net Working Capital. They are collected under our Net-Net screener.


Cencora Net Current Asset Value Related Terms

Thank you for viewing the detailed overview of Cencora's Net Current Asset Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Cencora Business Description

Address
1 West First Avenue, Conshohocken, PA, USA, 19428-1800
Cencora is one of three domestic leading pharmaceutical wholesalers. It sources and distributes branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. It and McKesson and Cardinal Health constitute over 90% of the us pharmaceutical wholesale industry. Cencora also provides commercialization services for manufacturers of pharmaceuticals and medical devices, global specialty drug logistics (World Courier), and animal health product distribution (MWI Animal Health). Cencora expanded its international presence in 2021 by purchasing Alliance Healthcare, one of the leading drug wholesalers in Europe.